Salmeterol/Fluticasonpropionat Devatis 25 μg/250 μg, Dosier-Aerosol

7680699030026 CH-69903 Dosier-Aerosol

Associated product:

SALMETEROL/FLUTICASONPROPIONAT Devatis 250 µg DA

No image available

Article details

Package size
120
Selling units
120
Measure
Einzeldose(n)
Galenic form
Dosier-Aerosol
Galenic group
Inhalation

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/10/2025
Patient information leaflet
Français
27/10/2025
Patient information leaflet
Italien
27/10/2025
Summary of Product Characteristics
Italien
27/10/2025
Summary of Product Characteristics
Allemand
27/10/2025
Summary of Product Characteristics
Français
27/10/2025

Detailed composition

Substance Quantity Type Category
salmeterolum
25.0 UG Substance Wirkstoff (Principe actif)
salmeteroli xinafoas
- Substance WIZUS
fluticasoni propionas
250.0 UG Substance Wirkstoff (Principe actif)
norfluranum
- Substance HFKW

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
69903
Drug name
Salmeterol/Fluticasonpropionat Devatis, Dosier-Aeroseol
Galenic form
GASDS
ATC Code
R03AK06
Authorization status
Z
Dispensing category
B
First authorization
16/09/2025
Authorization expiration date
15/09/2030
IT Number
03.04.3.
Domain
Human medicine
Field of application
Asthma

Package details

Description (FR)
SALMETEROL/FLUTICASONPROPIONAT Devatis 250 µg DA
Description (DE)
SALMETEROL/FLUTICASONPROPIONAT Devatis 250 µg DA
Market launch
01/12/2025
Narcotic (BTM)
No

Other package sizes (1)

SALMETEROL/FLUTICASONPROPIONAT Devatis 125µg DA
120 EINZ
GTIN: 7680699030019
View
Buy us a coffee Explore the data